GALEN LIMITED

PaymentCheck Score 2025
69Fair
vs last year
#2508 in UK
#19 in Life Sciences And Medical Technology
#31 in Northern Ireland

Company Information

Company Number
NI056542
Registered Address
Seagoe Industrial Estate, Craigavon, County Armagh, BT63 5UA
Status
Active
Employee Count
33
Turnover
£48,640,000
EBITDA
-£557,000

Additional Details

Company Type
Private limited Company
Incorporated On
16 September 2005
Nature of Business
46460 - Wholesale of pharmaceutical goods
Industries
Life Sciences And Medical Technology
Region
Northern Ireland

Time to Pay

Average Time to Pay
32 days
Shortest Period:30 days
Longest Period:0 days
Max Contractual:60 days

Payment Timeline

Within 30 Days
54%
31-60 Days
42%
After 60 Days
4%
Not Paid Within Terms36%

Payment Features

Participates in Codes✗ No
E-Invoicing✗ No
Supply Chain Finance✗ No

Payment Score History

Excellent (80+) Good (60-79) Fair (40-59) Poor (20-39) Very Poor (<20)

Performance Reports History

Reporting Period Filed: 2025-04-28
Reporting PeriodFiling DateAverage Time to Pay (days)Paid within 30 daysPaid 31-60 daysPaid after 60 daysNot Paid within Terms
01 Apr 2025 - 30 Sept 202522 Oct 20253248%47%5%13%
01 Oct 2024 - 31 Mar 202528 Apr 20253254%42%4%36%
01 Oct 2023 - 31 Mar 202429 Apr 20243259%37%4%32%
01 Apr 2023 - 30 Sept 202326 Oct 20233051%46%3%32%
01 Apr 2022 - 30 Sept 202217 Oct 20223432%65%3%43%
01 Apr 2021 - 30 Sept 202125 Oct 20213430%64%6%50%
01 Oct 2020 - 31 Mar 202116 Apr 20213729%64%7%54%
01 Apr 2019 - 30 Sept 201924 Oct 20193639%51%11%40%

Payment Time Trends

Payment Distribution Trends

Invoice Payment Practices

This information is as reported by the business, and responses are in their own words.

Payment Terms

Standard payment terms

The most frequently used terms were 30 days from the end of the month in which the invoice is dated.

Were there any changes to the standard payment terms in the reporting period?

No information available

Any other information about payment terms

Invoices are paid only if correctly presented with all necessary information and only when approved by the relevant buyer. As a result, payment terms may be impacted where time is required to resolve queries.

Maximum contractual payment period agreed

60

Dispute Resolution Process

Payment disputes are handled by the Accounts Payable team, which liaises with the suppliers and the company’s buyers as necessary to resolve invoice and payment queries in a timely manner. Where correction of an invoice is necessary, payment is processed as soon as reasonably practicable following receipt of corrected invoice. The Accounts Payable team may be contacted via a dedicated Accounts Payable mailbox or by telephone.

Other Payment Information

Has this business signed up to a code of conduct or standards on payment practices?

For example, signatories to The Prompt Payment Code must commit to paying 95% of their invoices within 60 days.

Does this business offer e-invoicing in relation to qualifying contracts?

This is where suppliers can electronically submit and track invoices. It's not just allowing suppliers to email them an invoice.

Does this business offer supply chain finance?

This is where a supplier who has submitted an invoice can be paid by a third-party finance provider earlier than the agreed payment date. The business would then pay the finance provider the invoiced sum.

Under its payment practices and policies, can this business deduct sums from payments under qualifying contracts as a charge for remaining on a supplier list?

During the reporting period, did the business deduct sums from payments as a charge for remaining on a supplier list?

No information available

Company Summary

GALEN LIMITED is a pharmaceutical company based in the United Kingdom that specializes in the development and distribution of a wide range of medicines and healthcare products. The company is committed to sustainability and has implemented several initiatives to reduce its environmental impact.

In terms of products and services, GALEN LIMITED offers a diverse portfolio of prescription and over-the-counter medicines, as well as medical devices and nutritional supplements. The company also provides services such as medical education and training, clinical trials, and product distribution.

The key people at GALEN LIMITED include CEO David Bennett, who has over 30 years of experience in the pharmaceutical industry, and the company's founder, Dr. Allen McClay. The company's sustainability program is led by a dedicated team that focuses on reducing carbon emissions, promoting responsible waste management, and implementing sustainable sourcing practices.

GALEN LIMITED's sustainability efforts have been recognized by various organizations, including being named the Sustainable Business of the Year at the 2020 UK Business Awards. The company is also a member of the United Nations Global Compact, demonstrating its commitment to ethical and sustainable business practices.

For more information on GALEN LIMITED and its products and services, as well as its sustainability program, interested parties can visit the company's website at www.galen-pharma.com. The registered office address for GALEN LIMITED is 5th Floor, Clarendon House, Victoria Avenue, Harrogate, North Yorkshire, HG1 1JD, United Kingdom.

Financial Metrics

Cash
£5,407,220
Net Worth
£25,586,488
Total Current Assets
£21,538,920
Total Current Liabilities
£27,291,901

Company Location